Trevor P. Castor

Company: Aphios

Job title: Chief Executive Officer

Seminars:

Utilizing Nanoencapsulated Cannabinoid Therapies for Chronic Treatment of Opiod Use Disorder 2:30 pm

Formulation to support the translation of cannabinoid – based therapies from acute to chronic therapeutic use Discussing the development of a combined CBD and naltrexone formulation designed to enhance efficacy and patient compliance in treating opioid use disorder Investigating the sustainability advantages of utilizing CO2 in the nanoencapsulation manufacturing process NEW DATARead more

day: Conference Day Two